Therapeutic Asset Ratings
329 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Slamf7 Fpbmc
Plasma Cell Myeloma
University of Virginia
P1/2
CC
(40)
Sti-6129
Plasma Cell Myeloma
Zhejiang ACEA Pharmaceutical Co. Ltd.
P1/2
CC
(40)
Syhx1903
Plasma Cell Myeloma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
P1/2
CC
(40)
Tazemetostat
Plasma Cell Myeloma
Bristol-Myers Squibb
P1/2
CC
(40)
tg01
Plasma Cell Myeloma
Oslo University Hospital
P1/2
CC
(40)
Zevor-Cel
Plasma Cell Myeloma
CARsgen Therapeutics Co., Ltd.
P1/2
CC
(40)
Zilurgisertib
Plasma Cell Myeloma
Incyte Corporation
P1/2
CC
(40)
cvd908ssb-txsvn
Plasma Cell Myeloma
Baylor College of Medicine
P1
C
(39)
ft576
Plasma Cell Myeloma
Fate Therapeutics
P1
C
(39)
Noraramtide
Plasma Cell Myeloma
Biohaven Pharmaceuticals, Inc.
P1
C
(39)
Telaglenastat
Plasma Cell Myeloma
National Cancer Institute (NCI)
P1
C
(39)
Xmab24306
Plasma Cell Myeloma
Genentech, Inc.
P1
C
(39)
Mirdametinib
Plasma Cell Myeloma
National Cancer Institute (NCI)
P1/2
C
(39)
Vactosertib
Plasma Cell Myeloma
David Wald
P1
C
(37)
3d189
Plasma Cell Myeloma
3D Medicines
P1
C
(36)
Abbv-438
Plasma Cell Myeloma
AbbVie
P1
C
(36)
anv419
Plasma Cell Myeloma
Anaveon AG
P1
C
(36)
Astatine At 211 Anti-Cd38 Monoclonal Antibody Okt10-B10
Plasma Cell Myeloma
Fred Hutchinson Cancer Center
P1
C
(36)
Bcma Car T Cells
Plasma Cell Myeloma
University College, London
P1
C
(36)
Bl-M24D1
Plasma Cell Myeloma
Sichuan Baili Pharmaceutical Co., Ltd.
P1
C
(36)
BMS-986453
Plasma Cell Myeloma
Susan Bal
P1
C
(36)
car138 t cells
Plasma Cell Myeloma
UNC Lineberger Comprehensive Cancer Center
P1
C
(36)
cd19-ucart
Plasma Cell Myeloma
Anhui Provincial Hospital
P1
C
(36)
Cxcr4 Modified Anti-Bcma Car T Cells
Plasma Cell Myeloma
Sichuan University
P1
C
(36)
Descartes-25
Plasma Cell Myeloma
Cartesian Therapeutics
P1
C
(36)
Showing 226 to 250 of 329 assets
Previous
Page 10 of 14
Next
